|
|
|
Volumn 14, Issue 6, 2001, Pages 373-384
|
|
New drug targets in inflammation and immunomodulation
a
a
NONE
(United Kingdom)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE;
A 169888;
A 285222;
A 285354;
ABT 222;
ADENOSINE A2 RECEPTOR AGONIST;
ANTIINFLAMMATORY AGENT;
AZD 2315;
BETA1 INTEGRIN;
BIO 1211;
BUDESONIDE;
CALCIUM;
CALCIUM CHANNEL;
CASPASE INHIBITOR;
CGP 54086;
CGS 27023A;
CHEMOKINE RECEPTOR CCR2;
CHEMOKINE RECEPTOR CCR3;
CYCLOSPORIN;
DNK 333;
DPC 333;
ETANERCEPT;
FLUTICASONE PROPIONATE;
FORMOTEROL FUMARATE;
GW 328267;
HALOPERIDOL;
IK 682;
IMMUNOGLOBULIN E ANTIBODY;
IMMUNOSUPPRESSIVE AGENT;
INFLIXIMAB;
INTERLEUKIN 5;
LEFLUNOMIDE;
MEPOLIZUMAB;
METHOTREXATE;
MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR;
NEW DRUG;
NVP AAQ128;
NVP AAQ359;
OMALIZUMAB;
R 110769;
RO 116 4875;
RO 139380;
RO 154063;
RO 320 967;
RO 330 0802;
RO 3300802;
RO 38170;
SALMETEROL XINAFOATE;
SB 282241;
SB 332255;
SB 380732;
SCH 55700;
TACHYKININ RECEPTOR ANTAGONIST;
TACROLIMUS;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VRT 18858;
ASTHMA;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG TARGETING;
HUMAN;
IMMUNOMODULATION;
INFLAMMATION;
NONHUMAN;
RHEUMATOID ARTHRITIS;
|
|
EID: 0034786450
PISSN: 02140934
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (4)
|
|
References (0)
|
